Mirati Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 798 matching filings.

Per page

25

Current page

3

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Jan 2024
Reporting date: 29 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87670

SC 13G/A filing

Filing date: 27 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 27 Dec 2023
Reporting date: 18 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 19 Dec 2023
Reporting date: 18 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35921

8-K

Filing date: 19 Dec 2023
Reporting date: 18 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 14 Dec 2023
Reporting date: 13 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35921

8-K

Filing date: 13 Dec 2023
Reporting date: 13 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-35921

FORM DEFA14A

Filing date: 06 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-35921

DEFA14A

Filing date: 01 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35921

8-K

Filing date: 24 Nov 2023
Reporting date: 17 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-35921

DEFA14A

Filing date: 15 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35921

8-K

Filing date: 13 Nov 2023
Reporting date: 10 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35921

8-K

Filing date: 06 Nov 2023
Reporting date: 06 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .